Back to Search
Start Over
Successful re-introduction of recombinant human erythropoietin following antibody induced pure red cell aplasia.
- Source :
-
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association [Nephrol Dial Transplant] 2004 Aug; Vol. 19 (8), pp. 2137-9. - Publication Year :
- 2004
- Subjects :
- Aged
Aged, 80 and over
Antibodies immunology
Cyclosporine therapeutic use
Darbepoetin alfa
Drug Resistance
Epoetin Alfa
Erythropoietin immunology
Erythropoietin therapeutic use
Humans
Immunosuppressive Agents therapeutic use
Male
Recombinant Proteins
Red-Cell Aplasia, Pure immunology
Reticulocyte Count
Retreatment
Erythropoietin administration & dosage
Erythropoietin adverse effects
Erythropoietin analogs & derivatives
Red-Cell Aplasia, Pure chemically induced
Renal Dialysis
Subjects
Details
- Language :
- English
- ISSN :
- 0931-0509
- Volume :
- 19
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
- Publication Type :
- Academic Journal
- Accession number :
- 15252175
- Full Text :
- https://doi.org/10.1093/ndt/gfh319